130 related articles for article (PubMed ID: 29917271)
1. From hepatofibrosis to hepatocarcinogenesis: Higher cytochrome P450 2E1 activity is a potential risk factor.
Gao J; Wang Z; Wang GJ; Gao N; Li J; Zhang YF; Zhou J; Zhang HX; Wen Q; Jin H; Qiao HL
Mol Carcinog; 2018 Oct; 57(10):1371-1382. PubMed ID: 29917271
[TBL] [Abstract][Full Text] [Related]
2. Higher CYP2E1 Activity Correlates with Hepatocarcinogenesis Induced by Diethylnitrosamine.
Gao J; Wang Z; Wang GJ; Zhang HX; Gao N; Wang J; Wang CE; Chang Z; Fang Y; Zhang YF; Zhou J; Jin H; Qiao HL
J Pharmacol Exp Ther; 2018 May; 365(2):398-407. PubMed ID: 29467309
[TBL] [Abstract][Full Text] [Related]
3. High CYP2E1 activity aggravates hepatofibrosis by limiting macrophage polarization towards the M2 phenotype.
Guo YY; Xu C; Fang Y; Wang CE; Gao N; Wen Q; Qiao HL
Mol Carcinog; 2019 Aug; 58(8):1481-1491. PubMed ID: 31116889
[TBL] [Abstract][Full Text] [Related]
4. High CYP2E1 activity correlates with hepatofibrogenesis induced by nitrosamines.
Gao J; Wang GJ; Wang Z; Gao N; Li J; Zhang YF; Zhou J; Zhang HX; Wen Q; Jin H; Qiao HL
Oncotarget; 2017 Dec; 8(68):112199-112210. PubMed ID: 29348818
[TBL] [Abstract][Full Text] [Related]
5. Higher Activity of Alcohol Dehydrogenase Is Correlated with Hepatic Fibrogenesis.
Gao N; Li J; Li MR; Qi B; Wang Z; Wang GJ; Gao J; Qiao HL
J Pharmacol Exp Ther; 2018 Dec; 367(3):473-482. PubMed ID: 30228113
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of cytochrome P450 2E1 is associated with poor prognosis of hepatocellular carcinoma.
Ho JC; Cheung ST; Leung KL; Ng IO; Fan ST
Int J Cancer; 2004 Sep; 111(4):494-500. PubMed ID: 15239125
[TBL] [Abstract][Full Text] [Related]
7. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo.
Kang JS; Wanibuchi H; Morimura K; Gonzalez FJ; Fukushima S
Cancer Res; 2007 Dec; 67(23):11141-6. PubMed ID: 18056438
[TBL] [Abstract][Full Text] [Related]
8. CYP2E1 triggered GRP78/ATF6/CHOP signaling axis inhibit apoptosis and promotes progression of hepatocellular carcinoma.
Ishteyaque S; Yadav KS; Verma S; Washimkar KR; Mugale MN
Arch Biochem Biophys; 2023 Sep; 745():109701. PubMed ID: 37499993
[TBL] [Abstract][Full Text] [Related]
9. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenic Etheno DNA Adducts in Alcoholic Liver Disease: Correlation with Cytochrome P-4502E1 and Fibrosis.
Mueller S; Peccerella T; Qin H; Glassen K; Waldherr R; Flechtenmacher C; Straub BK; Millonig G; Stickel F; Bruckner T; Bartsch H; Seitz HK
Alcohol Clin Exp Res; 2018 Feb; 42(2):252-259. PubMed ID: 29120493
[TBL] [Abstract][Full Text] [Related]
11. CYP2E1 deficit mediates cholic acid-induced malignant growth in hepatocellular carcinoma cells.
Hao Z; Liu X; He H; Wei Z; Shu X; Wang J; Sun B; Zhou H; Wang J; Niu Y; Hu Z; Hu S; Liu Y; Fu Z
Mol Med; 2024 Jun; 30(1):79. PubMed ID: 38844847
[TBL] [Abstract][Full Text] [Related]
12. Expression of cytochrome P4502E1 gene in hepatocellular carcinoma.
Man XB; Tang L; Qiu XH; Yang LQ; Cao HF; Wu MC; Wang HY
World J Gastroenterol; 2004 Jun; 10(11):1565-8. PubMed ID: 15162526
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of cytochrome P450 and possible correlation with preneoplastic changes in early stage of rat hepatocarcinogenesis.
Liu LL; Gong LK; Qi XM; Cai Y; Wang H; Wu XF; Xiao Y; Ren J
Acta Pharmacol Sin; 2005 Jun; 26(6):737-44. PubMed ID: 15916741
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 2E1 gene polymorphism and alcohol drinking on the risk of hepatocellular carcinoma: a meta-analysis.
Liu W; Tian F; Dai L; Chai Y
Mol Biol Rep; 2014 Nov; 41(11):7645-50. PubMed ID: 25185993
[TBL] [Abstract][Full Text] [Related]
15. Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma.
Zhou J; Wen Q; Li SF; Zhang YF; Gao N; Tian X; Fang Y; Gao J; Cui MZ; He XP; Jia LJ; Jin H; Qiao HL
Oncotarget; 2016 Aug; 7(31):50612-50623. PubMed ID: 27203676
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of CYP2E1 in hepatocellular carcinoma carcinogenesis: examination with newly prepared anti-human CYP2E1 antibody.
Hirose Y; Naito Z; Kato S; Onda M; Sugisaki Y
J Nippon Med Sch; 2002 Jun; 69(3):243-51. PubMed ID: 12068315
[TBL] [Abstract][Full Text] [Related]
17. [Association between aldehyde dehydrogenase-2/cytochrome P450 2E1 genetic polymorphism and habit of alcohol drinking and the susceptibility of hepatocellular carcinoma].
Ye X; Peng T; Liu T; Su Z; Xiao K; Shang L; Su M; Li L
Wei Sheng Yan Jiu; 2010 Jan; 39(1):42-5. PubMed ID: 20364586
[TBL] [Abstract][Full Text] [Related]
18. In vivo 1H MR spectroscopy in the evaluation of the serial development of hepatocarcinogenesis in an experimental rat model.
Xu H; Li X; Yang ZH; Xie JX
Acad Radiol; 2006 Dec; 13(12):1532-7. PubMed ID: 17138121
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in alcohol dehydrogenase (ADH1) and cytochrome p450 2E1 (CYP2E1) genes in patients with cirrhosis and/or hepatocellular carcinoma.
Gaviria-Calle M; Duque-Jaramillo A; Aranzazu M; Di Filippo D; Montoya M; Roldán I; Palacio N; Jaramillo S; Restrepo JC; Hoyos S; Navas MC
Biomedica; 2018 Dec; 38(4):555-568. PubMed ID: 30653870
[TBL] [Abstract][Full Text] [Related]
20. Heterologous expression of human cytochrome P450 2E1 in HepG2 cell line.
Zhuge J; Luo Y; Yu YN
World J Gastroenterol; 2003 Dec; 9(12):2732-6. PubMed ID: 14669323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
